老年患者围术期喉罩气道与术后肺部并发症的有效性与安全性(POLMA-EP试验):随机对照试验研究方案
这是一项多中心随机平行对照试验方案,计划纳入6000例年龄≥70岁、ASA分级1-2级、体重指数≤35 kg/m2的择期手术老年患者,随机分为喉罩组或气管插管组,比较两组术后肺部并发症发生率和围术期死亡率,随访至出院后12周。
要点
- 计划纳入6000例≥70岁择期手术老年患者,随机分为喉罩组与气管插管组。
- 主要结局为术后肺部并发症发生率和围术期死亡率。
- 随访通过电话进行,直至出院后12周。
核心结论
- 该试验将评估老年患者围术期使用喉罩 compared with 气管插管在术后肺部并发症发生和临床预后方面的可能获益或劣势。
- 研究者预期该试验将增进对老年人群术后肺部并发症的理解,并为老年外科管理的国际推荐提供依据。
研究设计与样本
- 多中心、随机、平行临床对照试验,计划纳入6000例年龄≥70岁、美国麻醉医师协会(ASA)分级1-2级、体重指数≤35 kg/m2的择期手术老年患者。
- 患者随机分为喉罩(LMA)组或气管插管(ETI)组,除采用喉罩/气管插管外,两组均接受常规围术期管理。
- 随访通过电话进行,直至出院后12周。
- 试验注册于ClinicalTrials.gov,注册号NCT02240901,注册日期2014年9月16日。
关键数值与推荐
- 主要结局为术后肺部并发症(PPCs)的发生率和患者围术期死亡率。
- 次要结局包括插管难易程度、麻醉药用量、PPCs治疗、手术时长、麻醉恢复时间和表现、PPCs发生时间、麻醉后监护室停留、重症监护室入住和停留、住院天数、再入院率、住院费用和患者满意度评分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: With the increasing amount of geriatric surgery, it has become a great challenge for anesthesiologists to reduce the incidence of postoperative pulmonary complications (PPCs). The two most popular airway management methods, laryngeal mask airway (LMA) and endotracheal intubation (ETI), both have their unique advantages in specific clinical settings. For the purpose of helping clinicians make better decisions on airway management during geriatric surgery, we designed this multi-center clinical trial to compare the influence of LMA and ETI on PPCs. METHODS/DESIGN: In this multi-center, randomized, parallel clinical trial, a total of 6000 elderly patients, aged ≥ 70 years, with an American Society of Anesthesiologists classification level of 1-2 and a body mass index ≤ 35 kg/m2, undergoing elective surgery will be enrolled and randomized into the LMA or the ETI group. Both groups will receive usual perioperative care except for the adoption of LMA/ETI. Primary outcomes are the occurrence of PPCs and patients' perioperative mortality rates. Ease of intubation, anesthetics consumption, treatment for PPCs, duration of surgery, anesthesia recovery time and performance, time of PPC onset, postanesthesia care unit stay, intensive care unit admission and stay, in-hospital days, re-admission rates, hospitalization cost, and patients' satisfactory scores will be secondary outcomes. Follow-up will be conducted through phone-call visits until 12 weeks after discharge. DISCUSSION: This trial will assess the possible benefits or disadvantages of perioperative LMA use in elderly patients compared with ETI regarding the occurrence of PPCs and clinical prognosis. We expect that this trial will also add to the current understanding of PPCs in geriatric populations and contribute to the international recommendations of geriatric surgery management. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02240901 . Registered on 16 September 2014.
引用
- Zhu L, Shi X, Yin S, et al. Effectiveness and pulmonary complications of perioperative laryngeal mask airway used in elderly patients (POLMA-EP trial): study protocol for a randomized controlled trial. Trials. 2019. PMID: 31068221. doi:10.1186/s13063-019-3351-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。